BioSenic SA
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BioSenic SA is a biotechnology company focused on developing innovative clinical-stage therapies for autoimmune diseases and regenerative medicine. The company's pipeline is centered on two main platforms: a novel treatment using arsenic trioxide (ATO) to target the underlying causes of autoimmune and inflammatory conditions, and an allogeneic cell therapy platform aimed at tissue repair and organ regeneration. Formerly known as Bone Therapeutics, BioSenic combines its expertise in immunomodulation and cell therapy to address significant unmet medical needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioSenic SA and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-29 18:00 |
ISS
BIOS_PR_EN_2025 08_29.pdf
|
French | 213.4 KB | |
| 2025-07-01 19:30 |
Capital/Financing Update
BIOS_PR_20250701_EN_final.pdf
|
English | 346.5 KB | |
| 2025-07-01 19:30 |
M&A Activity
BIOS_PR_20250701_FR_final.pdf
|
French | 342.1 KB | |
| 2025-06-10 07:30 |
Legal Proceedings Report
BIOS_PR_20250610_EN.pdf
|
English | 329.1 KB | |
| 2025-06-10 07:30 |
Capital/Financing Update
BIOS_PR_20250610-FR.pdf
|
French | 280.9 KB | |
| 2025-06-09 07:30 |
Capital/Financing Update
BIOS_PR_20250610_EN.pdf
|
English | 329.1 KB | |
| 2025-06-09 07:30 |
Legal Proceedings Report
BIOS_PR_20250610-FR.pdf
|
French | 280.9 KB | |
| 2025-05-08 18:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_April_Denominator_EN.pdf
|
English | 285.6 KB | |
| 2025-05-08 18:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_avril_Denominator_FR.pdf
|
French | 248.1 KB | |
| 2025-04-27 00:00 |
Report Publication Announcement
BIOS_PR_20250424_closing annual accounts_EN.pdf
|
English | 224.0 KB | |
| 2025-04-27 00:00 |
Report Publication Announcement
BIOS_PR_20250424-comptes annuels_FR.pdf
|
French | 236.5 KB | |
| 2025-04-10 18:00 |
Major Shareholding Notification
BIOS_PR_10042025- Notification_ABO_EN.pdf
|
English | 268.1 KB | |
| 2025-04-10 18:00 |
Major Shareholding Notification
BIOS_PR_10042025-Notification_ABO_FR.pdf
|
French | 300.6 KB | |
| 2025-04-07 20:30 |
Capital/Financing Update
BIOS_PR_20250407_EN.pdf
|
English | 285.2 KB | |
| 2025-04-07 20:30 |
Capital/Financing Update
BIOS_PR_20250407_FR.pdf
|
French | 245.9 KB |
Automate Your Workflow. Get a real-time feed of all BioSenic SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioSenic SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-24 | Rieger Francois | Board | Sell | 1,800,000 | 17,460.00 EUR |
| 2024-07-23 | Rieger Francois | Board | Sell | 3,835,063 | 41,329.76 EUR |
| 2024-07-23 | POMI SCHNEITER VERONIQUE | Board | Sell | 35,367 | 371.35 EUR |
| 2024-07-22 | POMI SCHNEITER VERONIQUE | Board | Sell | 63,616 | 680.69 EUR |
| 2024-07-19 | POMI SCHNEITER VERONIQUE | Board | Sell | 60,419 | 664.61 EUR |
| 2024-07-18 | POMI SCHNEITER VERONIQUE | Board | Sell | 166,692 | 1,883.62 EUR |
| 2024-07-18 | Rieger Francois | Board | Sell | 2,541,231 | 33,572.44 EUR |
| 2024-07-17 | POMI SCHNEITER VERONIQUE | Board | Sell | 294,983 | 3,480.80 EUR |
| 2024-07-16 | POMI SCHNEITER VERONIQUE | Board | Sell | 210,562 | 2,758.36 EUR |
| 2024-07-11 | POMI SCHNEITER VERONIQUE | Board | Sell | 1,413,303 | 19,079.59 EUR |
